Monsanto’s $2.25 Billion Fine for Roundup Cancer Link: Latest Updates and News

2024-01-27 01:16:39

New fine for Monsanto. The subsidiary of the German giant Bayer was ordered Friday by the jury of a court in Philadelphia (north-east) to pay $2.25 billion in damages to a man who accused the weedkiller Roundup of being origin of his cancer.

The glyphosate was classified, in 2015, as a “probable carcinogen” by the International Agency for Research on Cancer of the World Health Organization (OMS). For its part, the European Food Safety Authority (EFSA) indicated that it had not identified any “area of ​​critical concern” in humans, animals or in the environment likely to prevent the authorization of the herbicide, while recognizing a lack of data.

More than 10 billion dollars

According to Bayer, 113,000 of the approximately 165,000 proceedings initiated once morest Monsanto and related to weedkiller have been resolved or declared inadmissible to date.

In June 2020, the pharmaceutical and biotechnology giant reached an amicable agreement covering, according to the company, approximately 75% of the 125,000 actions then in progress. The transaction provided for the payment of a total sum of between $10.1 and $10.9 billion.

Bayer also dedicated 400 million dollars to compensate people exposed to another herbicide, dicamba, and 820 million for disputes linked to PCBs (polychlorinated biphenyls), so-called eternal pollutants. In 2021, the company allocated an additional $4.5 billion to manage these procedures, bringing the total envelope to more than $16 billion.

1706325287
#Monsanto #ordered #pay #billion #damages

Leave a Replay